631 filings
Page 24 of 32
8-K
qq0vw xtqk92
8 May 08
BioDelivery Sciences Presenting Phase III Data on BEMA™ Fentanyl
12:00am
424B3
s2zo7 nn4
26 Mar 08
Prospectus supplement
12:00am
EFFECT
ylw30ua hy
24 Mar 08
Notice of effectiveness
12:00am
CORRESP
6dx9 1jw93
20 Mar 08
Correspondence with SEC
12:00am
UPLOAD
ivudnb
17 Mar 08
Letter from SEC
12:00am
10-K/A
evi0 d971
17 Mar 08
Annual report (amended)
12:00am
10-K
vbk6yk2
7 Mar 08
Annual report
12:00am
8-K
f8p0gu30tnrwgt9b
14 Jan 08
FDA Accepts for Filing the BEMATM Fentanyl NDA
12:00am
8-K
jve0ox6jef ko28z5
14 Nov 07
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:00am
10QSB
80otk 31zq5n
14 Nov 07
Quarterly report (small business)
12:00am
8-K
e3xwo4xc8
2 Nov 07
Company to Hold Conference Call and Webcast at 2 PM EST Today to Discuss the NDA
12:00am
8-K
ejact
14 Sep 07
BDSI Receives $30 Million Upfront Payment Under BEMATM
12:00am
8-K
gfxd uahwlzkbk2l5ja7
12 Sep 07
Entry into a Material Definitive Agreement
12:00am
8-K
y4mh0f
10 Sep 07
BDSI Secures U.S. Commercial Partnership
12:00am
10QSB
129aiylutjdo19n
14 Aug 07
Quarterly report (small business)
12:00am
8-K
o683dd80h9
30 Jul 07
Charter of the Lead Director
12:00am
8-K
llw4b 32hjp0zhx146d
27 Jul 07
Other Events
12:00am
424B3
8rmj5
3 Jul 07
Prospectus supplement
12:00am
25
zrqmx0nptcqs4sy3v
3 Jul 07
Voluntary exchange delisting
12:00am